361 related articles for article (PubMed ID: 27548152)
41. Phosphocholine-decorated superparamagnetic iron oxide nanoparticles: defining the structure and probing in vivo applications.
Luchini A; Irace C; Santamaria R; Montesarchio D; Heenan RK; Szekely N; Flori A; Menichetti L; Paduano L
Nanoscale; 2016 May; 8(19):10078-86. PubMed ID: 26751053
[TBL] [Abstract][Full Text] [Related]
42. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
43. Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration.
Pham BTT; Colvin EK; Pham NTH; Kim BJ; Fuller ES; Moon EA; Barbey R; Yuen S; Rickman BH; Bryce NS; Bickley S; Tanudji M; Jones SK; Howell VM; Hawkett BS
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29320407
[TBL] [Abstract][Full Text] [Related]
44. Kinetic analysis of superparamagnetic iron oxide nanoparticles in the liver of body-temperature-controlled mice using dynamic susceptibility contrast magnetic resonance imaging and an empirical mathematical model.
Murase K; Assanai P; Takata H; Matsumoto N; Saito S; Nishiura M
Magn Reson Imaging; 2015 Jun; 33(5):600-10. PubMed ID: 25683514
[TBL] [Abstract][Full Text] [Related]
45. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.
Sharifi S; Seyednejad H; Laurent S; Atyabi F; Saei AA; Mahmoudi M
Contrast Media Mol Imaging; 2015; 10(5):329-55. PubMed ID: 25882768
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms for cellular uptake of nanosized clinical MRI contrast agents.
Guggenheim EJ; Rappoport JZ; Lynch I
Nanotoxicology; 2020 May; 14(4):504-532. PubMed ID: 32037933
[TBL] [Abstract][Full Text] [Related]
47. Magnetic separation of encapsulated islet cells labeled with superparamagnetic iron oxide nano particles.
Mettler E; Trenkler A; Feilen PJ; Wiegand F; Fottner C; Ehrhart F; Zimmermann H; Hwang YH; Lee DY; Fischer S; Schreiber LM; Weber MM
Xenotransplantation; 2013; 20(4):219-26. PubMed ID: 23789985
[TBL] [Abstract][Full Text] [Related]
48. Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.
Zhang B; Jiang B; Chen Y; Huang H; Xie Q; Kang M; Zhang H; Zhai C; Wu Y
Contrast Media Mol Imaging; 2012; 7(1):35-44. PubMed ID: 22344878
[TBL] [Abstract][Full Text] [Related]
49. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.
Pernal S; Wu VM; Uskoković V
ACS Appl Mater Interfaces; 2017 Nov; 9(45):39283-39302. PubMed ID: 29058880
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and characterization of dextran stabilized superparamagnetic iron oxide nanoparticles for in vivo MR imaging of liver fibrosis.
Saraswathy A; Nazeer SS; Nimi N; Arumugam S; Shenoy SJ; Jayasree RS
Carbohydr Polym; 2014 Jan; 101():760-8. PubMed ID: 24299836
[TBL] [Abstract][Full Text] [Related]
51. Biotechnological approach to induce human fibroblast apoptosis using superparamagnetic iron oxide nanoparticles.
Ferraz FS; López JL; Lacerda SMSN; Procópio MS; Figueiredo AFA; Martins EMN; Guimarães PPG; Ladeira LO; Kitten GT; Dias FF; Domingues RZ; Costa GMJ
J Inorg Biochem; 2020 May; 206():111017. PubMed ID: 32120160
[TBL] [Abstract][Full Text] [Related]
52. Biodistribution and pharmacokinetic studies of SPION using particle electron paramagnetic resonance, MRI and ICP-MS.
Gobbo OL; Wetterling F; Vaes P; Teughels S; Markos F; Edge D; Shortt CM; Crosbie-Staunton K; Radomski MW; Volkov Y; Prina-Mello A
Nanomedicine (Lond); 2015; 10(11):1751-60. PubMed ID: 26080697
[TBL] [Abstract][Full Text] [Related]
53. Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo.
Xie H; Zhu Y; Jiang W; Zhou Q; Yang H; Gu N; Zhang Y; Xu H; Xu H; Yang X
Biomaterials; 2011 Jan; 32(2):495-502. PubMed ID: 20970851
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles.
Zolata H; Abbasi Davani F; Afarideh H
Nucl Med Biol; 2015 Feb; 42(2):164-70. PubMed ID: 25311750
[TBL] [Abstract][Full Text] [Related]
55. Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent.
Prashant C; Dipak M; Yang CT; Chuang KH; Jun D; Feng SS
Biomaterials; 2010 Jul; 31(21):5588-97. PubMed ID: 20434210
[TBL] [Abstract][Full Text] [Related]
56. Accumulation and biological effects of cobalt ferrite nanoparticles in human pancreatic and ovarian cancer cells.
Pašukonienė V; Mlynska A; Steponkienė S; Poderys V; Matulionytė M; Karabanovas V; Statkutė U; Purvinienė R; Kraśko JA; Jagminas A; Kurtinaitienė M; Strioga M; Rotomskis R
Medicina (Kaunas); 2014; 50(4):237-44. PubMed ID: 25458961
[TBL] [Abstract][Full Text] [Related]
57. Mannose-poly(ethylene glycol)-linked SPION targeted to antigen presenting cells for magnetic resonance imaging on lymph node.
Muthiah M; Vu-Quang H; Kim YK; Rhee JH; Kang SH; Jun SY; Choi YJ; Jeong YY; Cho CS; Park IK
Carbohydr Polym; 2013 Feb; 92(2):1586-95. PubMed ID: 23399193
[TBL] [Abstract][Full Text] [Related]
58. Surface design of core-shell superparamagnetic iron oxide nanoparticles drives record relaxivity values in functional MRI contrast agents.
Maity D; Zoppellaro G; Sedenkova V; Tucek J; Safarova K; Polakova K; Tomankova K; Diwoky C; Stollberger R; Machala L; Zboril R
Chem Commun (Camb); 2012 Dec; 48(93):11398-400. PubMed ID: 23066527
[TBL] [Abstract][Full Text] [Related]
59. Surface functionalization of superparamagnetic nanoparticles for the development of highly efficient magnetic resonance probe for macrophages.
Huang C; Neoh KG; Wang L; Kang ET; Shuter B
Contrast Media Mol Imaging; 2011; 6(4):298-307. PubMed ID: 21287679
[TBL] [Abstract][Full Text] [Related]
60. Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects.
Xu HL; Mao KL; Huang YP; Yang JJ; Xu J; Chen PP; Fan ZL; Zou S; Gao ZZ; Yin JY; Xiao J; Lu CT; Zhang BL; Zhao YZ
Nanoscale; 2016 Aug; 8(29):14222-36. PubMed ID: 27396404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
